| Kerala Ayurveda Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530163 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE817B01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 34.64 |
Market Cap(₹Cr) : 278.16 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 22.07 | 21.29 | 17.57 | 20.63 | 20.73 | 18.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 1.28 | 1.38 | 0.00 |
| Net Sales | 22.07 | 21.29 | 17.57 | 19.35 | 19.35 | 18.60 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.98 | 2.26 | 10.00 | 4.37 | 0.13 | 0.39 |
| Total Income | 23.04 | 23.55 | 27.56 | 23.72 | 19.48 | 18.99 |
| Total Expenditure | 24.13 | 26.33 | 22.99 | 30.34 | 18.99 | 19.15 |
| PBIDT | -1.09 | -2.78 | 4.57 | -6.62 | 0.50 | -0.16 |
| Interest | 1.98 | 2.54 | 0.77 | 2.81 | 0.38 | 0.33 |
| PBDT | -3.07 | -5.32 | 3.80 | -9.42 | 0.12 | -0.49 |
| Depreciation | 0.58 | 0.55 | 1.23 | 1.46 | 0.28 | 0.22 |
| Tax | -0.18 | -0.47 | 0.51 | 0.98 | -0.08 | -0.17 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -3.47 | -5.40 | 2.07 | -11.86 | -0.08 | -0.54 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -3.47 | -5.40 | 2.07 | -11.86 | -0.08 | -0.54 |
| EPS (Unit Curr.) | -3.03 | -4.58 | 1.73 | -10.13 | -0.07 | -0.38 |
| EPS (Adj) (Unit Curr.) | -3.03 | -4.58 | 1.73 | -10.13 | -0.07 | -0.38 |
| Calculated EPS (Unit Curr.) | -2.88 | -4.48 | 1.72 | -9.86 | -0.07 | -0.45 |
| Calculated EPS (Adj) (Unit Curr.) | -2.88 | -4.48 | 1.72 | -9.86 | -0.07 | -0.45 |
| Calculated EPS (Ann.) (Unit Curr.) | -11.52 | -17.91 | 6.87 | -39.44 | -0.27 | -1.79 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -11.52 | -17.91 | 6.87 | -39.44 | -0.27 | -1.79 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.06 | 12.06 | 12.03 | 12.03 | 12.03 | 12.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -4.94 | -13.06 | 26.01 | -34.21 | 2.58 | -0.86 |
| PBDTM(%) | -13.91 | -24.99 | 21.63 | -48.68 | 0.62 | -2.63 |
| PATM(%) | -15.72 | -25.36 | 11.78 | -61.29 | -0.41 | -2.90 |
